- Home
- IMNM vs INSW Comparison
IMNM vs INSW Comparison
Compare IMNM & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | INSW |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | 168 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNM | INSW |
|---|---|---|
| Price | $19.35 | $48.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $26.89 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 1.2M | 496.3K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 6.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.39 |
| Revenue | $9,679,000.00 | ★ $770,036,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.22 |
| P/E Ratio | ★ N/A | $11.06 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.15 | $27.20 |
| 52 Week High | $20.80 | $55.18 |
Technical Indicators
Market Signals| Indicator | IMNM | INSW |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 36.67 |
| Support Level | $18.87 | $48.30 |
| Resistance Level | $20.80 | $49.90 |
| Average True Range (ATR) | 1.22 | 1.30 |
| MACD | -0.02 | -0.67 |
| Stochastic Oscillator | 70.80 | 10.18 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.